CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
批准号:
2215732
负责人:
David Joseph Riley
金额:
$26.82万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-08-01 至 1996-07-31
关键词:
blood pressure cellular pathology collagenase endopeptidases extracellular matrix extracellular matrix proteins fluorescence spectrometry guinea pigs hypoxia immunocytochemistry in situ hybridization interleukin 1 laboratory mouse laboratory rabbit laboratory rat mast cell mechanical pressure molecular genetics newborn animals protease inhibitor protein metabolism pulmonary artery pulmonary hypertension tissue /cell culture tumor necrosis factor alpha vascular endothelium vasodilation
中文摘要
慢性肺动脉高压的血管重构被认为是
包括精心制作刺激细胞增殖的介质,
肺动脉(PA)中基质蛋白的合成。 之甚少
然而,我们知道,导致退化的过程
降低PA压力后的重塑。 我们观察到
令人惊讶地快速恢复到主PA的正常结构,
大鼠缺氧性肺动脉高压的恢复。 我们推测
肺动脉压的降低会刺激血管中的蛋白酶
壁降解细胞和细胞外基质蛋白,
这些过程类似于那些调节从胎儿
与新生儿的成人肺动脉结构相对应。 这一假设可以在
成年大鼠缺氧性肺动脉高压(10和30天
暴露于10%O2),在新生大鼠和分离的PA环中,其中
壁张力突然降低。 有证据表明肥大细胞
是胶原分解的关键效应细胞,肥大细胞的作用是
将在肥大细胞缺陷小鼠和肥大细胞中研究退化的细胞。
细胞培养。 我们建议确定蛋白水解途径,
降解细胞内和细胞外基质蛋白以及
金属蛋白酶组织抑制剂(TIMP)使用生化和
分子生物学方法。 我们还将描述一个明显的
使用分子遗传学方法的血管特异性弹性蛋白酶,和
使用免疫组织化学确定蛋白酶的细胞来源,
原位杂交技术。 肿瘤坏死因子的作用
α、白细胞介素-1和脱粒剂刺激合成
或从培养的肥大细胞释放胶原酶。 我们
将确定参与蛋白质降解的特定蛋白酶,
孤立的PA环,其由壁的突然减小刺激
张力 这些实验可能表明,PA感觉到壁中的减少,
当血压降低和“渐开线”的激活紧张
来源于PA壁中特定细胞的蛋白酶。 这些研究可能
提出了肺血管重构发病机制新概念
这可能与慢性肺动脉高压有关。
英文摘要
Vascular remodeling in chronic pulmonary hypertension is thought to
involve elaboration of mediators that stimulate cell proliferation and
synthesis of matrix proteins in the pulmonary artery (PA). Little is
known, however, about the processes which lead to regression of
remodeling following lowering of PA pressure. We have observed
surprisingly rapid retum to normal structure of the main PA following
recovery from hypoxic pulmonary hypertension in the rat. We postulate
that reduction in PA pressure stimulates proteases in the blood vessel
wall to degrade cellular and extracellular matrix proteins, and that
these processes are similar to those regulating the transition from fetal
to adult PA structure in the neonate. This postulate win be tested in
adult rats recovering from hypoxic pulmonary hypertension (10 and 30 day
exposure to 10% 02), in neonatal rats and in isolated PA rings in which
wall tension is abruptly reduced. Evidence suggests that the mast cells
are a key effector cell in breakdown of collagen, and the role of mast
cells in regression will be studied in mast cell deficient mice and mast
cells in culture. We propose to identify the proteolytic pathways which
degrade intracellular and extracellular matrix proteins as well as the
tissue inhibitor of metalloprotease (TIMP) using biochemical and
molecular biology approaches. We will also characterize an apparently
vascular-specific elastase using molecular genetics methods, and
determine the cellular sources of proteases using immunohistochemical and
in situ hybridization techniques. The role of tumor necrosis factor
alpha, interleukin-1 and a degranulating agent in stimulating synthesis
or release of collagenase from cultured mast cells will be tested. We
will identify specific proteases involved in degradation of proteins in
isolated PA rings which are stimulated by abrupt reduction in wall
tension. These experiments may show that PAs sense reduction in wall
tension when blood pressure is lowered and "involute" by activation of
proteases derived from specific cells in the PA wall. These studies may
lead to new pathogenetic concepts about pulmonary vascular remodeling
which may be pertinent to chronic pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCLERODERMA LUNG STUDY
-
批准号:6389945
-
项目类别:
-
资助金额:$18.95万
-
财政年份:1999
-
负责人:David Joseph Riley
-
依托单位:
SCLERODERMA LUNG STUDY
-
批准号:6642048
-
项目类别:
-
资助金额:$18.23万
-
财政年份:1999
-
负责人:David Joseph Riley
-
依托单位:
SCLERODERMA LUNG STUDY
-
批准号:2899539
-
项目类别:
-
资助金额:$7.22万
-
财政年份:1999
-
负责人:David Joseph Riley
-
依托单位:
SCLERODERMA LUNG STUDY
-
批准号:6537407
-
项目类别:
-
资助金额:$20.57万
-
财政年份:1999
-
负责人:David Joseph Riley
-
依托单位:
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SSC ALVEOLITIS
-
批准号:6184512
-
项目类别:
-
资助金额:$9.48万
-
财政年份:1999
-
负责人:David Joseph Riley
-
依托单位:
FAMILIAL PULMONARY FIBROSIS
-
批准号:3362825
-
项目类别:
-
资助金额:$21.85万
-
财政年份:1990
-
负责人:David Joseph Riley
-
依托单位:
FAMILIAL PULMONARY FIBROSIS
-
批准号:3362827
-
项目类别:
-
资助金额:$1.64万
-
财政年份:1990
-
负责人:David Joseph Riley
-
依托单位:
FAMILIAL PULMONARY FIBROSIS
-
批准号:3362826
-
项目类别:
-
资助金额:$24.19万
-
财政年份:1990
-
负责人:David Joseph Riley
-
依托单位:
RESPIRATORY BIOLOGY
-
批准号:2212386
-
项目类别:
-
资助金额:$9.54万
-
财政年份:1980
-
负责人:David Joseph Riley
-
依托单位:
RESPIRATORY BIOLOGY
-
批准号:2212387
-
项目类别:
-
资助金额:$7.04万
-
财政年份:1980
-
负责人:David Joseph Riley
-
依托单位:
RESPIRATORY BIOLOGY
-
批准号:3541079
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1980
-
负责人:David Joseph Riley
-
依托单位:
RESPIRATORY BIOLOGY
-
批准号:3541074
-
项目类别:
-
资助金额:$9.12万
-
财政年份:1980
-
负责人:David Joseph Riley
-
依托单位:
RESPIRATORY BIOLOGY
-
批准号:3541080
-
项目类别:
-
资助金额:$9.55万
-
财政年份:1980
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337564
-
项目类别:
-
资助金额:$23.28万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337566
-
项目类别:
-
资助金额:$21.37万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337567
-
项目类别:
-
资助金额:$21.55万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337560
-
项目类别:
-
资助金额:$22.15万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
PREVENTION OF LUNG INJURY BY A PROLINE ANALOGUE
-
批准号:3337563
-
项目类别:
-
资助金额:$14.94万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337561
-
项目类别:
-
资助金额:$20.55万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
CELLS AND EXTRACELLULAR MATRIX IN PULMONARY HYPERTENSION
-
批准号:3337565
-
项目类别:
-
资助金额:$22.93万
-
财政年份:1979
-
负责人:David Joseph Riley
-
依托单位:
海外基金